HUP0002718A2 - Piperazinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények - Google Patents

Piperazinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0002718A2
HUP0002718A2 HU0002718A HUP0002718A HUP0002718A2 HU P0002718 A2 HUP0002718 A2 HU P0002718A2 HU 0002718 A HU0002718 A HU 0002718A HU P0002718 A HUP0002718 A HU P0002718A HU P0002718 A2 HUP0002718 A2 HU P0002718A2
Authority
HU
Hungary
Prior art keywords
substituted
piperazine derivatives
preparation
same
medicaments containing
Prior art date
Application number
HU0002718A
Other languages
English (en)
Inventor
Gerd Bartoszyk
Henning Böttcher
Hartmut Greiner
Christoph Seyfried
Original Assignee
Merck Patent Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh. filed Critical Merck Patent Gmbh.
Publication of HUP0002718A2 publication Critical patent/HUP0002718A2/hu
Publication of HUP0002718A3 publication Critical patent/HUP0002718A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

A találmány (I) általános képletű piperazinszármazékokra vonatkozik,amelyek képletében R1 jelentése szubsztituálatlan vagy egyszeresenvagy kétszeresen halogénatommal, CN-, A-, AO-, HO-, -CONH2, -CONHA, -CONA2, -COOH, -COOA, -CH2OH, -CH2OA, -CH2NH2, -CH2NHA és/vagy -CH2NA2csoporttal szubsztituált indol-3-il-csoport, R2 jelentéseszubsztituálatlan vagy egyszeresen vagy kétszeresen halogénatommal,A-, AO-, -OH, CN-, -NO2, -NH2, -NHA, -NA2, -COA, -CONH2, -CONAH, -CONA2, -CH2OH, -CH2OA, -CH2NH2, -CH2NHA, -CH2NA2, -COOH és/vagy -COOAcsoporttal szubsztituált 2-oxo-2H-1-benzopirán-6-il- vagy 2-oxo-2H-1-benzopirán-4-il-csoport, Hal jelentése fluor-, klór-, bróm, vagyjódatom, A jelentése egyenes vagy elágazó szénláncú, 1-10 szénatomosalkilcsoport, amely 1-5 fluor- és/vagy klóratommal lehetszubsztituált, vagy jelentése 3-10 szénatomos cikloalkilcsoport, és mértéke 2, 3 vagy 4. A vegyületeknek befolyásolják a szerotoninergtranszmissziót. Ó
HU0002718A 1997-07-18 1998-06-29 Piperazine derivatives, process for their preparation and medicaments containing the same HUP0002718A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19730989A DE19730989A1 (de) 1997-07-18 1997-07-18 Piperazin-Derivate
PCT/EP1998/003956 WO1999003855A1 (de) 1997-07-18 1998-06-29 Piperazin-derivate

Publications (2)

Publication Number Publication Date
HUP0002718A2 true HUP0002718A2 (hu) 2001-10-28
HUP0002718A3 HUP0002718A3 (en) 2001-11-28

Family

ID=7836208

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002718A HUP0002718A3 (en) 1997-07-18 1998-06-29 Piperazine derivatives, process for their preparation and medicaments containing the same

Country Status (23)

Country Link
US (1) US6251908B1 (hu)
EP (1) EP0998474B1 (hu)
JP (1) JP2001510193A (hu)
KR (1) KR100528684B1 (hu)
CN (1) CN1093127C (hu)
AR (1) AR010932A1 (hu)
AT (1) ATE353326T1 (hu)
AU (1) AU731332B2 (hu)
BR (1) BR9810607A (hu)
CA (1) CA2296687A1 (hu)
DE (2) DE19730989A1 (hu)
ES (1) ES2281131T3 (hu)
HU (1) HUP0002718A3 (hu)
ID (1) ID24663A (hu)
MY (1) MY132794A (hu)
NO (1) NO20000216D0 (hu)
PL (1) PL191078B1 (hu)
RU (1) RU2194048C2 (hu)
SK (1) SK352000A3 (hu)
TW (1) TW425398B (hu)
UA (1) UA59407C2 (hu)
WO (1) WO1999003855A1 (hu)
ZA (1) ZA986390B (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244846B2 (en) 2001-03-14 2007-07-17 Merck Patent Gmbh Substituted benzofuran-2-carboxamides derivatives

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287018B6 (sk) * 1999-08-23 2009-09-07 Solvay Pharmaceuticals B. V. Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
BR0115296A (pt) * 2000-11-14 2003-09-02 Merck Patent Ges Mit Beschonkt Uso de inibidores de recaptação de sorotonina e agonistas de 5ht1a combinados
AR032712A1 (es) 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
US7504395B2 (en) 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
DE10259244A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh N-(Indolethyl-)cycloamin-Verbindungen
DE10305739A1 (de) 2003-02-11 2004-08-19 Merck Patent Gmbh Benzofuranderivate
DE10315285A1 (de) 2003-04-04 2004-10-14 Merck Patent Gmbh Chromenonindole
GT200600414A (es) * 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
US8822728B2 (en) 2008-04-17 2014-09-02 Thomas Daly Biological buffers with wide buffering ranges
US8334402B2 (en) * 2008-04-17 2012-12-18 Thomas Daly Biological buffers with wide buffering ranges
US9447310B2 (en) 2008-04-17 2016-09-20 Thomas P. Daly Biological buffers with wide buffering ranges
US20170313920A1 (en) 2010-10-06 2017-11-02 Thomas P. Daly Biological Buffers with Wide Buffering Ranges
US9090638B2 (en) 2008-04-17 2015-07-28 Thomas Daly Biological buffers with wide buffering ranges
US7939659B2 (en) * 2008-04-17 2011-05-10 Thomas Daly Biological buffers with wide buffering ranges
US8519141B2 (en) 2008-04-17 2013-08-27 Thomas Daly Biological buffers with wide buffering ranges
US8034951B2 (en) * 2008-04-17 2011-10-11 Thomas Daly Biological buffers with wide buffering ranges
US7635791B2 (en) * 2008-04-17 2009-12-22 Tpat Ip Llc Biological buffers with wide buffering ranges
EP2374459A1 (en) * 2008-05-30 2011-10-12 Psychogenics Inc. Treatment for neurological and mental disorders
CA2760465A1 (en) 2009-05-12 2010-11-18 Transgene Sa Method for orthopoxvirus production and purification
CN102206214B (zh) * 2011-04-07 2014-03-12 华中科技大学 苯并吡喃酮类衍生物及其应用
US9475754B2 (en) 2011-10-06 2016-10-25 Thomas P. Daly Biological buffers with wide buffering ranges
BR112014028841B1 (pt) * 2012-05-23 2021-01-12 Nerviano Medical Sciences S.R.L. Formas cristalinas 1 e 2, composição farmacêutica, uso da forma cristalina 1 para o tratamento de um estado de doença tratável pela inibição de alk e processo para a preparação de n-[5-(3,5-difluoro-benzil)-1h-indazol-3-il]-4-(4-metilpiperazin-1-il)-2-(tetra-hidro-piran-4-ilamino)- benzamida
US9598401B2 (en) 2013-07-29 2017-03-21 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
CN105418506B (zh) * 2014-09-19 2018-04-24 上海医药工业研究院 乙酰苄胺哌嗪类衍生物及其作为脑神经保护剂的应用
WO2016192657A1 (en) 2015-06-03 2016-12-08 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB146691A (en) * 1919-05-29 1920-07-15 William Herbert Tripp Apparatus for indicating and recording side drift or leeway of aircraft
FR2189027B1 (hu) * 1972-06-21 1976-03-05 Leurquin Laboratoires Fr
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
WO1998004542A1 (en) * 1996-07-26 1998-02-05 Nissan Chemical Industries, Ltd. Chroman derivatives
WO1999005140A1 (en) * 1997-07-25 1999-02-04 H. Lundbeck A/S Indole and 2,3-dihydroindole derivatives, their preparation and use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244846B2 (en) 2001-03-14 2007-07-17 Merck Patent Gmbh Substituted benzofuran-2-carboxamides derivatives

Also Published As

Publication number Publication date
UA59407C2 (uk) 2003-09-15
PL191078B1 (pl) 2006-03-31
CN1093127C (zh) 2002-10-23
DE19730989A1 (de) 1999-01-21
AR010932A1 (es) 2000-07-12
CA2296687A1 (en) 1999-01-28
HUP0002718A3 (en) 2001-11-28
RU2194048C2 (ru) 2002-12-10
TW425398B (en) 2001-03-11
ATE353326T1 (de) 2007-02-15
DE59813899D1 (de) 2007-03-22
AU731332B2 (en) 2001-03-29
EP0998474B1 (de) 2007-02-07
ES2281131T3 (es) 2007-09-16
AU8730298A (en) 1999-02-10
NO20000216L (no) 2000-01-17
KR20010021957A (ko) 2001-03-15
PL338075A1 (en) 2000-09-25
MY132794A (en) 2007-10-31
BR9810607A (pt) 2000-07-11
CN1264379A (zh) 2000-08-23
SK352000A3 (en) 2000-06-12
WO1999003855A1 (de) 1999-01-28
NO20000216D0 (no) 2000-01-17
ZA986390B (en) 1999-05-24
JP2001510193A (ja) 2001-07-31
EP0998474A1 (de) 2000-05-10
ID24663A (id) 2000-07-27
US6251908B1 (en) 2001-06-26
KR100528684B1 (ko) 2005-11-15

Similar Documents

Publication Publication Date Title
HUP0002718A2 (hu) Piperazinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
BR9900984A (pt) Processo para testar a pureza ou a estabilidade à degradação de uma amostra de lamotrigina ou de uma forma de dosagem farmacêutica compreendendo lamotrigina e para produzir um composto, composto n-[5-amino6(2,3-dicloro-fenil)- 1,2,4-triazina-3-il] -2,3 - dicloro benzamida, amostra de composto, e, uso de um composto selecionado de 3-amino-6-(2,3-dicloro-fenil)-1,2,4-triazinas-5-(4h)-ona e n-[5-amino-6-(2,3-dicloro-fenil)-1,2,4-triazina-3-il]-2,3-di cloro-benzamida.
SE0202483D0 (sv) Chemical compounds
NO20012977L (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
NL300091I2 (nl) Interleukine-1 remmers.
BR0209153A (pt) Indol, azaindol e derivados de amidopiperazina heterocìclicos relacionados
ATE221879T1 (de) Kristalline paclitaxel hydrate
DE50005437D1 (en) Substituierte thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one
FI963169A (fi) Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
FI952734A (fi) 2-Amino-6-A-propyyli-amino-4,5,6,7-tetrahydrobentsotiatsolin (Pramipexolin) käyttö lääkeaineena, jolla on antidepressiivinen vaikutus
EP0216345A3 (en) Quinoline derivatives
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
IT1232823B (it) Forme di somministrazione solide, che si decompongono rapidamente, relativo procedimento di produzione e loro impiego
NO964451L (no) Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer
ES2018208B3 (es) Derivados de hidroxipirazol, procedimiento para su obtencion y su aplicacion contra microorganismos.
AUPP223198A0 (en) New use
NZ284853A (en) 1-(azacycloalkyl)-7-(arylalkoxy)naphthalene derivatives; medicaments
NO941084D0 (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
ES2195545T3 (es) Derivados de triazolopurina, composicion medicinal que contiene los derivados, agnete compatibilizante del receptor a3 de adenosina y remedio contra el asma.
HUP9900263A2 (hu) 11-Acetil-12,13-dioxabiciklo[8.2.1]tridecenon-származékok, eljárás ezek előállítására és az e vegyületeket tartalmazó gyógyászati készítmények
EE05184B1 (et) Kaloporosiidi derivaadid, nende valmistamine ja kasutamine ravimina, neid sisaldavad ravimid ning mikroorganismi Gloeoporus dichrous (Fr.:Fr.) tvi ST001714 (DSM 13784)
ATE75746T1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung.
DK0673913T3 (da) Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
AU567498B2 (en) 5-phenyl-1h-2,3-dihydro-1,4-benzodiazepine derivatives.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees